Neurotoxicity caused by traditional chemotherapy and radiotherapy is widely recognized in
patients with cancer. The adverse effects of newer therapeutics, such as biological and …

Molecularly targeted cancer therapies, such as small-molecule kinase inhibitors and
monoclonal antibodies, constitute a rapidly growing and an important part of the oncology …

Chronic inflammation promotes endothelial plasticity, leading to the development of several
diseases, including fibrosis and cancer in numerous organs. The basis of those processes is …

Chemotherapy and radiation therapy are two of the major modalities used to treat cancer.
Central or peripheral nervous system toxicity is common and often dose limiting …

Neurologic complications of cancer are common and are frequently life-threatening events.
Certain neurologic emergencies occur more frequently in the cancer population, specifically …

Patients with brain tumors and systemic malignancies are subject to diverse neurologic
complications that require urgent evaluation and treatment. These neurologic conditions are …

Anlotinib is an oral multi-targeted tyrosine kinase inhibitor as a third-line and subsequent
treatment for patients with small cell lung cancer (SCLC) in China. The neurotoxicity is less …

Background: The occurrence of acute ischemic stroke in cancer patients is not unusual. In
clinical practice, acute ischemic stroke with cancer usually cannot be diagnosed promptly …

Neurologists are often consulted for diagnosis and management of neurologic complications
in patients undergoing therapy for cancer. Pediatric patients with cancer, often undergoing …

The process of mammalian reproduction involves the development of fertile germ cells in the
testis and ovary, supported by the surrounders. Fertilization leads to embryo development …